NASDAQ: FBLG · Life Sciences · 3 alerts · CIK 1958777
Share price
$0.9034Close, Nov 16
Market cap
$8.12M
Shares outstanding
8.99MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All FibroBiologics, Inc. filings on SEC EDGAR ↗
FibroBiologics closed a $0.5 million private placement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for the purchase of 298,508 shares and accompanying warrants. The securities were sold at a combined purchase price of $1.675 per unit, with proceeds intended for general corporate purposes and working capital. Additionally, shareholders approved the issuance of over 8 million shares related to a prior June 2026 securities purchase agreement.
FibroBiologics entered into a securities purchase agreement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for a private placement of 298,508 shares and equal warrants. The offering is expected to raise approximately $0.5 million in gross proceeds for general corporate purposes and working capital. The securities were priced at $1.675 per unit, representing the previous day's closing bid price plus a warrant premium.